Mechanisms of B Cell Responses in Autoimmune Disease: A Randomized, Double-Blind, Placebo-Controlled, Phase II Multicenter Trial of a Monoclonal Antibody to CD20 (Rituxibab) for the Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)

Grant

Date/time Interval

  • May 1, 2010 - April 30, 2012

    • Awarded By

    Total Award Amount

  • 474690.00

    • Direct Costs

  • 394282.00

    • Sponsor Award Id

  • C10

    • Contributor

  • Robert Bourge   Principal Investigator